SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Health Canada has granted marketing authorization of DAYBUE™ (trofinetide) for the treatment of Rett ...

The all-new third-gen GMC Acadia made its big debut for the 2024 model year, introducing larger exterior dimensions, revised exterior styling, additional interior room, new tech features, and a new ...

Earlier this week at the 2023 Detroit Auto Show, General Motors officially unveiled the all-new, next-generation 2024 GMC Acadia, which will go on sale in the U.S. in early 2024. Now, The General has ...

SAN DIEGO--(BUSINESS WIRE)-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Health Canada has accepted its New Drug Submission (NDS) for trofinetide for the treatment of Rett syndrome ...

Shares of Acadia Pharmaceuticals (NASDAQ: ACAD) were soaring 18.3% higher as of 11:03 a.m. ET on Friday. The big jump came after the drugmaker announced on Thursday that it has acquired expanded ...

Detailed price information for Acadia Pharmaceutica (ACAD-Q) from The Globe and Mail including charting and trades.

Want a home-grown mid-sized SUV? You’ve come to the right place. It’s the Jeep Grand Cherokee vs GMC Acadia. The Jeep Grand Cherokee and GMC Acadia are two modern, comfortable offerings that can ...

At Halifax, Dartmouth and on Cape Breton Island, thirsty Nova Scotians queued up on the sidewalk white shutters came down, doors were opened and government liquor stores began to operate for the first ...

--DAYBUE is the first and only therapy approved in Canada for the treatment of Rett syndrome, a rare, neurodevelopmental disorder SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) ...